| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/03/2000 | EP0996622A1 Novel spiroazabicyclic heterocyclic compounds |
| 05/03/2000 | EP0743940B1 New compounds with analgesic and local anaesthetic effect |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 05/03/2000 | CN1251999A Stable extract of hypericum perforatum L.,method for producing same and corresponding pharmaceutical preparations |
| 05/03/2000 | CN1251987A Dasage forms comprising separate portions of R- and S-enantiomers |
| 05/02/2000 | US6057488 Metal oxide adsorbent and halogens fot targets |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056968 Pharmaceutical drug dosage forms providing different release rates |
| 05/02/2000 | US6056962 Isolation and formulations of nutrient-rich carotenoids |
| 05/02/2000 | US6056961 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis |
| 05/02/2000 | CA2136411C Immediate release tablet cores of insoluble drugs having sustained release coating |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 05/02/2000 | CA1340979C Silane derivatives, processes for their preparation, agents containing them, and their use as pesticides |
| 04/27/2000 | WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | EP0995742A1 Sulfonamide compounds and medicinal use thereof |
| 04/26/2000 | EP0994880A1 Crystalline macrolides and process for their preparation |
| 04/26/2000 | EP0994872A1 4-phenylpiperidine compounds |
| 04/26/2000 | EP0994713A1 USE OF A 7$g(a)-METHYL-17$g(a)-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 04/26/2000 | EP0626853B1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/26/2000 | CN1251573A Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/25/2000 | US6054434 8a-azalides as veterinary antimicrobal agents |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | CA2181241C Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/20/2000 | WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 04/20/2000 | WO2000021528A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | WO2000003742A3 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 04/20/2000 | DE19847969A1 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| 04/20/2000 | CA2346867A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/19/2000 | EP0993452A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | CN1251129A Use of antibacterial active substance triclocarbance in liquid soaps |
| 04/19/2000 | CN1251101A Salt of naphthyridine carobxylic acide derivative |
| 04/19/2000 | CN1250669A Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 04/18/2000 | US6051564 Phosphatidic acid-comprising compositions |
| 04/18/2000 | US6051554 Cyclized peptides |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051238 Stabilizers for lyophilized mumps vaccines |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020073A2 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000001415A3 Use of inhibitors of protein kinase c epsilon to treat pain |
| 04/13/2000 | WO1999062451A9 Topical transdermal treatments |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/12/2000 | EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/12/2000 | EP0991641A1 Omeprazole sodium salt |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991625A2 Inhibitors of factor xa with a neutral p1 specificity group |
| 04/11/2000 | US6048898 Synthesis of glatiramer acetate (copolymer-1) |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048845 Antiulcer agent; mixture of cyclodextri ad cytotoxic drug |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048549 Powder compositions |
| 04/11/2000 | CA1340955C Stilbene derivatives |
| 04/06/2000 | WO2000018366A1 Oral composition with an improved teeth whitening effect |
| 04/05/2000 | EP0990437A1 Aerosol compositions |
| 04/05/2000 | EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds |
| 04/05/2000 | EP0957895A4 Shaving composition and method for preventing pseudofolliculitis barbae |
| 04/05/2000 | EP0765308B1 Enzyme inhibitors |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/05/2000 | CN1051096C Oligomers, their uses and formulations |
| 04/05/2000 | CN1050996C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine |
| 04/05/2000 | CN1050992C Method for dyeing hair and complete set of hair-dyestuff |
| 04/04/2000 | US6046233 Agent for treating cor pulmonale |
| 04/04/2000 | US6045778 Stabilized medicinal aerosol solution formulations |
| 03/30/2000 | WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000016796A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 03/30/2000 | WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations |
| 03/30/2000 | WO2000016757A2 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 03/30/2000 | WO2000016746A2 Immunogenic liposome compositions |
| 03/30/2000 | WO2000016736A1 Oral care compositions |
| 03/30/2000 | WO2000016732A2 ANTI-MICROBIAL-ADHESION FRACTION DERIVED FROM $i(VACCINIUM) |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations |
| 03/30/2000 | DE19844003A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents e.g. for treating viral infections, tumors, inflammation or autoimmune disease |
| 03/30/2000 | DE19843222A1 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen Use of organophosphorus compounds for therapeutic and prophylactic treatment of infections |
| 03/30/2000 | CA2345242A1 Anti-microbial-adhesion fraction derived from vaccinium |
| 03/30/2000 | CA2344867A1 Use of aminoalkylphosphonic acid derivatives for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 03/30/2000 | CA2344370A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 03/30/2000 | CA2342976A1 Oral care compositions |
| 03/29/2000 | EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 03/29/2000 | EP0988055A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier |
| 03/29/2000 | CN1248910A Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 03/29/2000 | CN1248909A Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 03/29/2000 | CN1248435A Keratin fibre dyeing composition using cation direct dye and thickening polymer |
| 03/29/2000 | CN1248434A Keratin fibre dyeing composition using cation direct dye and thickening polymer |
| 03/29/2000 | CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use |
| 03/29/2000 | CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process |
| 03/28/2000 | US6042840 Component of a skin care agent |
| 03/28/2000 | CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics |
| 03/26/2000 | CA2403011A1 Apparatus for electrical moxibustion using the extract |